Interní Med. 2017; 19(3): 220-222

Co nového o apixabanu přinesl kongres ESC 2017?

prof. MUDr. Petr Neužil, CSc., FESC
Nemocnice Na Homolce, Praha

Published: July 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Neužil P. Co nového o apixabanu přinesl kongres ESC 2017? Interní Med. 2017;19(3):220-222.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ezekowitz M, et al., 2017, EMANATE, oral presentation at ESC 2017, abstract number 3055.
    2. Li X, et al, 2017, poster presentation at ESC 2017, poster number 3588.
    3. Garrison LP, Neumann PJ, Erickson P, Marshall D, Mullins CD. Using real-world data for coverage and payment decisions: the ISPOR real-world data task force report. Value Health. 2007; 10: 326-335. Go to original source... Go to PubMed...
    4. Hannan EL. Randomized clinical trials and observational studies. J Am Coll Cardiol Intv. 2008; 1: 211-217. Go to original source... Go to PubMed...
    5. Deitelzweig S, et al. Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies, Current Medical Research and Opinion, 2017: 1583-1594. Go to original source... Go to PubMed...
    6. January CT. ACC/AHA/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation. 2014; 130: E212-E212. Go to original source...
    7. Eagle KA. Management of Atrial Fibrillation: Translating Clinical Trial Data into Clinical Practice. The American Journal of Medicine. 2011; 124: 4-14. Go to original source...
    8. Wolf PA, et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991; 22: 983-898. Go to original source... Go to PubMed...
    9. Granger BCH, et al. Apixaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med. 2011. Go to original source...
    10. Noseworthy AP, et al. Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation. CHEST. 2016. Go to original source...
    11. Tirschwell DL, Longstreth W. Validating administrative data in stroke research Stroke. 2002; 33(10): 2465-2470. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.